Drug-induced fever: a pharmacovigilance analysis based on the FDA adverse event reporting system

This large-scale pharmacovigilance analysis identified drugs and patient characteristics associated with drug-induced fever and revealed early-onset patterns, providing evidence to support its early recognition and monitoring in clinical practice.